The maker of Zepbound and Mounjaro launched a new platform to connect patients and prescribers.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2024-01-05 22:40:352024-01-05 22:40:35Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.